NCT00005076View on ClinicalTrials.gov

Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

cetuximab

DRUG

irinotecan hydrochloride

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT00005076 - Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter